
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our…

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our…
Core tech: opti-ox deterministic cell programming
Product focus: ioCells research products and txCells therapeutics pipeline
Founded: 2016 (Cambridge, UK)
Recent funding: $50M Series C (Jan 2026)
Employee count: 174
Human cell sourcing variability and scalability for research, drug discovery and cell therapy development.
2016
Biotechnology Research
$103 million
First close reported at $103M with participation from institutional and strategic investors
$30 million
Company announcement of $30M financing led by M&G Investments
$50 million
Series C announced and closed Jan 9, 2026
$41.5 million
“M&G Investments as repeat lead/participant alongside institutional investors such as Arch Venture Partners, Foresite Capital and others”
bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.
As a team of individuals, we value science, collaboration, openness, curiosity and creativity. We are united by trust and respect for each other.
bit.bio is seeking a strategic and commercially driven Director of Business Development, Data & Platform Partnerships to lead go-to-market (GTM) strategy and revenue generation for our Data as a Product (DaaP) and platform assets. This role focuses on building high-value strategic partnerships that integrate our causal, deterministic human datasets and platform into the wider predictive biology and AI-enabled drug discovery ecosystem.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week
| Company |
|---|
Your key responsibilities will include: Strategic Data, Platform Partnerships & Business Development
AI/ML, Data & Platform Collaboration Strategy
End-to-End Partnership Deal Leadership
Portfolio Strategy
Cross-Functional Leadership
You…
With essential experience in…
…and possibly…
More reasons to join us: bit.bio provides a vibrant and dynamic work environment in an exciting, fast-moving time for biology. We work with cutting edge technologies and with our world-leading scientific advisory board. We conduct pioneering work with real-world impact.
We trust our people to make significant contributions early on with opportunities to be involved in projects that are key to the success and growth of our young company. We invest in people, creating opportunities for personal development in an inclusive multi-skilled team with ambitious goals that provide opportunities to learn on the job from each other.
Creativity and open minds are encouraged for everyone to contribute to the success of the company.
For information on how we will manage your data please see our Candidate Privacy Notice